MSMalathi Sellapan

Malathi Sellapan

*This is an algorithmically generated author record based on publicly available information.

Malathi Sellapan has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    AI-Driven Drug Repurposing through miRNA-mRNA Relation

    by Sharanya Manoharan, Balu Bhasuran, Oviya Ramalakshmi Iyyappan, Mohamed Saleem Abdul Shukkoor, Malathi Sellapan, Kalpana Raja

    miRNA mRNA relations are closely linked to several biological processes and disease mechanisms In a recent study we tested the performance of large language models LLMs on extracting miRNA mRNA relations from PubMed PubMedBERT achieved the best performance of 0.783 F1 score for miRNA mRNA Interaction Corpus MMIC Here we first applied the finetuned PubMedBERT model to extract miRNA mRNA relations from PubMed for chronic obstructive pulmonary disease COPD Alzheimers disease AD stroke type 2 diabetes mellitus T2DM chronic liver disease and cancer Next we retrieved miRNA drug relations using KinderMiner a literature mining tool for relation extraction Then we constructed three interaction networks 1 disease centric network 2 drug centric network and 3 miRNA centric network comprising 3497 nodes and 16417 edges organized as a directed graph to capture complex biological relationships Finally we validated the drugs using MIMIC IV Our integrative approach revealed both established and novel candidate drugs for diseases under study through 595 miRNA drug relations extracted from PubMed To the best of our knowledge this is the first study to systematically extract and visualize relationships among four distinct biomedical entities miRNA mRNA drug and disease

  • Open Access

    A Comprehensive Review on Jackfruit Composite Materials and Sustainable Applications

    by S Malathi, A Leelavathi, S.M Arthi, M.S Soorya

    In recent years, there has been a growing interest in the development of sustainable materials to address the environmental challenges posed by conventional synthetic materials. Jackfruit (Artocarpusheterophyllus), a tropical fruit native to South and Southeast Asia, has emerged as a promising candidate for sustainable composite materials due to its abundant availability, low cost, and unique combination of mechanical and chemical properties. This review emphasizes the sustainable aspects of jackfruit composites, focusing on their biodegradability, renewability, and eco-friendly characteristics. The environmental impact and life cycle analysis of jackfruit-based materials are discussed, underlining their potential to reduce the carbon footprint associated with conventional materials.The latter part of the article highlights the wide-ranging applications of jackfruit composite materials. Case studies and examples from recent research demonstrate the practical feasibility and performance of these materials in real-world applications. Challenges and future perspectives in the development and commercialization of jackfruit composites are also discussed, emphasizing the need for continued research in areas such as processing optimization, scalability, and cost-effectiveness.In conclusion, this comprehensive review provides valuable insights into the burgeoning field of jackfruit composite materials, offering a holistic understanding of their synthesis, properties, and applications in material engineering.

  • Development and Validation of HPTLC Method for the Estimation of Escitalopram oxalate and Flupentixol Dihydrochloride in Pharmaceutical Formulation

    by S. Malathi, H. Ananthi

    A simple, precise, accurate High-performance thin-layer chromatography (HPTLC) method has been developed and validated for the estimation of escitalopram oxalate (ESC) and flupentixol dihydrochloride (FLU) in pharmaceutical formulation. Separation was achieved on an aluminum HPTLC plate coated with a 0.2 mm layer of silica gel 60 F254 with chloroform: methanol 4:6 (v/v) as mobile phase. The densitometry analysis was carried out in absorbance mode at 254 nm. The Rf values of escitalopram and flupentixol were 0.24 and 0.44 respectively. The linearity of the method was achieved in the range 3-7 µg/spot for ESC with correlation coefficient value 0.998 and 0.3-0.7µg/spot for FLU with correlation coefficient value 0.999. The developed method was validated according to ICH guidelines and the results were statistically validated. The limit of detection and quantification for escitalopram oxalate and flupentixol dihydrochloride was found to be 500 ng/spot and 50 ng/spot, 1000 ng/spot, and 100 ng/spot respectively.